日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cells

一种利用基因工程改造的人类诱导多能干细胞衍生的自然杀伤细胞治疗肺癌的创新疗法

Sato, Yuka; Goto, Kumiko; Yagishita, Shigehiro; Miyata, Kotoko; Uesugi, Noriko; Torisawa, Yu-Suke; Naritomi, Yoichi; Takahashi, Ryuta; Sho, Rumiko; Takeno, Yuriko; Kurachi, Kenji; Yamada, Masashi; Higashi, Yasuyuki; Kimura, Hironobu; Hamada, Akinobu; Nishigaki, Fusako; Tamura, Kouichi

Production of phenols from a cyclic sugar alcohol in high-temperature water over a charcoal-supported platinum catalyst

在高温水中,以活性炭负载铂催化剂为催化剂,由环状糖醇制备酚类化合物。

Yamazaki, Kiyoyuki; Samata, Rumiko; Hiyoshi, Norihito; Sato, Osamu; Yamaguchi, Aritomo

A Novel Dysferlin-Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy

一种新型的肌营养不良蛋白结合激酶CK2α促进肌营养不良蛋白病中的质膜修复

Naoko Nakamura,Naoki Suzuki,Shin-Ichiro Kanno,Rei Yamanaka,Hiroya Ono,Rumiko Izumi,Rui Muliang,Christian Borgo,Akiyuki Ohno,Ryuhei Harada,Saki Saito,Yukino Funayama,Kensuke Ikeda,Shio Mitsuzawa,Yasuaki Watanabe,Tomomi Shijo,Tetsuya Akiyama,Toshiaki Takahashi,Makoto Kanzaki,Shion Osana,Hitoshi Warita,Yoshitsugu Aoki,Satoru Ebihara,Mauro Salvi,Ryoichi Nagatomi,Akira Yasui,Katsuya Miyake,Masashi Aoki

Facts and Issues of Submitting Applications (Public Knowledge-Based Applications) for Unapproved and Off-label Drugs With High Medical Needs in Japan

日本高医疗需求未获批准和超适应症用药申请(基于公共知识的申请)的事实和问题

Hinomura, Akiko; Obata, Daisuke; Matsubayashi, Jun; Yamanaka, Mayumi; Yamada, Koji; Hosoki, Rumiko; Kutsumi, Hiromu; Morita, Shin-Ya; Kasama, Shu

Frailty Assessed Using the FRAIL-NH Scale and its Associations with Long-Term Care Needs in Residents of Japanese Nursing Homes: A Multicenter Cross-Sectional Study

使用FRAIL-NH量表评估衰弱程度及其与日本养老院居民长期护理需求的关联:一项多中心横断面研究

Hamada, Shota; Tsuchiya-Ito, Rumiko; J Liau, Shin; Hattori, Yukari; Bell, J Simon; Sakata, Nobuo

Physcomitrium LATERAL SUPPRESSOR genes promote formative cell divisions to produce germ cell lineages in both male and female gametangia

绒毛藻侧向抑制基因促进形成性细胞分裂,从而在雄性和雌性配子囊中产生生殖细胞谱系。

Horiuchi, Yuta; Umakawa, Naoyuki; Otani, Rina; Tamada, Yosuke; Kosetsu, Ken; Hiwatashi, Yuji; Wakisaka, Rena; Yoshida, Saiko; Murata, Takashi; Hasebe, Mitsuyasu; Ishikawa, Masaki; Kofuji, Rumiko

The transcription factor PpRKD evokes female developmental fate in the sexual reproductive organs of Physcomitrium patens

转录因子PpRKD诱导小立碗藓(Physcomitrium patens)性生殖器官的雌性发育命运。

Yoro, Emiko; Suzuki, Seiya; Akiyoshi, Nobuhiro; Kofuji, Rumiko; Sakakibara, Keiko

Oz Virus Infection in 6 Animal Species, Including Macaques, Bears, and Companion Animals, Japan

日本6种动物(包括猕猴、熊和伴侣动物)感染Oz病毒

Matsuu, Aya; Tatemoto, Kango; Ishijima, Keita; Nishino, Ayano; Inoue, Yusuke; Park, Eunsil; Tamatani, Hiroo; Seto, Junji; Higashi, Hideo; Fukui, Yuichi; Noma, Takashi; Doi, Kandai; Nakashita, Rumiko; Isawa, Haruhiko; Kasai, Shinji; Maeda, Ken

Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trial

奥佐拉利珠单抗 30 mg 对甲氨蝶呤疗效不佳的类风湿性关节炎患者的早期疗效:一项 II/III 期 OHZORA 试验的事后轨迹分析

Miyazaki, Yusuke; Horiuchi, Nobuko; Okamoto, Shunsuke; Matsumoto, Rumiko; Takeuchi, Tsutomu; Tanaka, Yoshiya

Efficacy of ozoralizumab in rheumatoid arthritis patients with large joint involvement: a post hoc analysis of OHZORA and NATSUZORA trials

奥佐拉利珠单抗治疗大关节受累类风湿关节炎患者的疗效:OHZORA 和 NATSUZORA 试验的事后分析

Ebina, Kosuke; Okamoto, Shunsuke; Kyuuma, Masanao; Horiuchi, Nobuko; Matsumoto, Rumiko; Etani, Yuki; Noguchi, Takaaki; Tanaka, Yoshiya; Takeuchi, Tsutomu